Placental blood for bone marrow replacement: The New York Blood Center's program and clinical results

Best Practice and Research: Clinical Haematology

Volumn 13, Issue 4, 2000, Pages 565-584

  Rubinstein, Pablo ^a   Stevens, Cladd E ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

Cord blood banking; Placental umbilical cord blood; Unrelated bone marrow transplantation

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; CRYOPRESERVATION; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HEALTH CENTER; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INFORMATION PROCESSING; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; PLACENTA; PRIORITY JOURNAL; RECURRENCE RISK; REGRESSION ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; UNITED STATES;

EID: 0034523953     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2000.0106     Document Type: Article

References (49)

1. Fresh and stored placental blood
2. Hematopoietic transplantation by means of fetal (cord) blood: A new method
3. In vitro growth of granulocytic colonies from circulating cells in human cord blood
4. Haematopoietic stem cells (CFUc) in human cord blood
5. Granuloerythropoietic colonies in human bone marrow, peripheral blood and cord blood
6. Hematopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors
7. Cryopreservation of pluripotent and committed hemopoietic progenitor cells from human bone marrow and cord blood
8. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells
9. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults
10. Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood. U.S
11. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling
12. Transplantation of umbilical cord blood after myeloablative therapy: Analysis of engraftment
13. HLA-mismatched cord blood transplantation in a patient with advanced leukemia
14. Umbilical cord blood infusion in a patient for correction of Wiskott-Aldrich syndrome
15. Cord blood transplantation in thalassemia
16. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation
17. Allogeneic sibling umbilical-cord blood transplantation in children with malignant and non-malignant disease
18. Outcome of cord blood transplantation from related and unrelated donors
19. Placental blood-derived hematopoietic stem cells for unrelated bone marrow reconstitution
20. Stored placental blood for unrelated bone marrow reconstitution
21. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation
22. Unrelated placental blood for bone marrow reconstitution: Organization of the placental blood program
23. Transplantation tolerance
24. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment for acute and chronic leukemia
25. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings
26. Bone marrow donor registries: The relation between registry size and probability of finding complete and partial matches
27. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor
28. Graft-versus-leukemia reactions after bone marrow transplantation
29. Can cord blood be used?
30. Cord blood banking for potential future transplantation: Subject review
31. Monoclonal origin of T-cell malignancy in identical twins
32. Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins
33. Backtracking leukemia to birth
34. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots
35. Proceedings and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution
36. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
37. Outcomes among 562 recipients of placental blood transplants from unrelated donors
38. Optimal processing of human umbilical cord blood for clinical banking
39. Cord blood banking: Volume reduction of cord blood units using a semi-automated closed system
40. Engraftment of human cord blood stem cells separated by stem cell collection filter (SCF) in NOD/SCID mice: Evidence for maintenance of SCID-repopulating activity
41. Evaluation of a new device for volume reduction of placental blood units by filtration through polyurethane
42. Nonparametic estimation from incomplete observations
43. Regression models and life tables (with discussion)
44. Unrelated donor umbilical cord blood transplantation at Duke University and at the University of Minnesota: Results in 143 patients
45. Factors associated with outcome after cord blood transplantation in children with acute leukemia
46. An HLA matched donor? An HLA matched donor? What do you mean by an HLA matched donor?
47. Standards and efficiency of cord blood banking by the international Netcord organisation